A Survey for Assessment of Effectiveness of Fluoxetine on Motor Improvement in Ischemic Stroke Patients

Not Applicable

• Conditions: stroke.; Middle cerebral artery syndrome

• Registration Number: IRCT201312088323N7
• Lead Sponsor: Kermanshah University of Medical Science

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 150

Inclusion Criteria

inclusion criteria: stroke in middle cerebral artery( documented with imaging) and the patient have a hemi or mono plegy or paresis?the patient was not comatose ? filling the agreemnet sheet with patient or a reliable attendant ? the patient is dischargable and not admitted in ICU ward
exclusion criteria: death of patient with any cause in duration of study ? irregular use of drugs ? irregular return for reexaminations ? presence of seizure, severe diarrhea, vomiting, severe insomnia ? presence of metabolic disorder( hyperthyroidism, hepatic , renal, cardiac,...) ? past medical history of psychiatric disorder or severe depression before stroke ? presence of SAH, lobar ICH, brain tumor ? stroke in other vascular territories (MCA, ACA,...) ? simmultaneous use of MAO-i , Selegiline, Cyproheptadine.

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Motor deficit and psychiatric disorder. Timepoint: before study,day 45, day 90. Method of measurement: Hamilthon depression rating Scale(HDRS) for psychiatric disorders and Barthel Index( BI ) for motor assessment.